Statistical flag only — not an accusation of fraud
⚠️ This provider averages 548 services per working day — physically unusual for an individual practitioner
Based on 1.4M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $18.0M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 548 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 588% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 68/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 89% in 2018
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $79.50 | $17.75 | 4.48x | $61.75 | $462.1K | 26.0K | 37 |
| 2015 | $33.52 | $8.88 | 3.77x | $24.64 | $586.1K | 66.0K | 41 |
| 2016 | $36.81 | $9.66 | 3.81x | $27.15 | $813.7K | 84.3K | 40 |
| 2017 | $33.28 | $7.97 | 4.18x | $25.31 | $694.5K | 87.2K | 47 |
| 2018 | $45.99 | $10.99 | 4.18x | $35.00 | $1.3M | 119.5K | 48 |
| 2019 | $54.11 | $15.50 | 3.49x | $38.61 | $2.3M | 149.6K | 50 |
| 2020 | $50.23 | $14.06 | 3.57x | $36.17 | $2.7M | 188.7K | 58 |
| 2021 | $47.66 | $12.55 | 3.80x | $35.11 | $3.0M | 239.5K | 62 |
| 2022 | $53.82 | $14.19 | 3.79x | $39.63 | $2.9M | 207.1K | 62 |
| 2023 | $60.22 | $15.67 | 3.84x | $44.55 | $3.2M | 202.8K | 63 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 88.6K | $3.5M | $39.63 | 2.66x |
| J2505 | Injection, pegfilgrastim, 6 mg | 730 | $2.2M | $3.0K | 4.15x |
| J9299 | Injection, nivolumab, 1 mg | 95.0K | $2.1M | $22.63 | 2.55x |
| J0897 | Injection, denosumab, 1 mg | 84.5K | $1.3M | $15.79 | 2.80x |
| J9312 | Injection, rituximab, 10 mg | 12.2K | $865.4K | $70.92 | 2.86x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 21.8K | $791.2K | $36.33 | 2.48x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 868 | $610.0K | $702.79 | 6.06x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 5.0K | $500.4K | $100.30 | 3.59x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 5.2K | $440.0K | $84.35 | 2.38x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 498 | $419.9K | $843.16 | 2.09x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 7.4K | $383.7K | $51.99 | 2.47x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 363.8K | $311.4K | $0.86 | 3.59x |
| J9035 | Injection, bevacizumab, 10 mg | 5.2K | $289.1K | $55.47 | 3.00x |
| J9041 | Injection, bortezomib, 0.1 mg | 9.4K | $254.8K | $27.17 | 3.86x |
| J9022 | Injection, atezolizumab, 10 mg | 3.7K | $235.4K | $64.33 | 2.63x |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 2.4K | $232.8K | $98.94 | 10.48x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 18.2K | $188.6K | $10.36 | 2.94x |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 3.4K | $188.0K | $54.88 | 2.81x |
| J2469 | Injection, palonosetron hcl, 25 mcg | 18.2K | $167.9K | $9.22 | 11.82x |
| Q5117 | Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | 4.7K | $166.2K | $35.23 | 5.44x |
This provider submits charges 3.79 times higher than what Medicare actually pays.
A markup ratio of 3.79x means for every $100 Medicare pays, this provider initially charges $379. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in SC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Renwick Goldberg, MD | Myrtle Beach, SC | $38.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data